Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

CUSIP: 48576U106

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
126,468,243
Total 13F shares
60,912,948
Share change
-63,593
Total reported value
$41,204,113
Put/Call ratio
46%
Price per share
$0.68
Number of holders
87
Value change
-$289,373
Number of buys
32
Number of sells
39

Quarterly Holders Quick Answers

What is CUSIP 48576U106?
CUSIP 48576U106 identifies KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q4 2024

As of 31 Dec 2024, Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) was held by 87 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 60,912,948 shares. The largest 10 holders included VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., Palo Alto Investors LP, BlackRock, Inc., MORGAN STANLEY, CITADEL ADVISORS LLC, MARSHALL WACE, LLP, Catalio Capital Management, LP, Eversept Partners, LP, and Avidity Partners Management LP. This page lists 87 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.